Mental Depression and Cardiovascular Disease: A Multifaceted, Bidirectional Association

ABSTRACT

The association between cardiovascular disease and mental depression is multifaceted and likely bidirectional. Depressed patients are at significantly higher risk for cardiac morbidity and mortality even in the absence of a diagnosis of major depression, whereas mental depression is nearly 3 times more frequent in patients after an acute myocardial infarction and contributes to a worse prognosis. Therefore, depressed patients might become trapped in a harmful loop, where mental symptoms might be worsened by the synergistic effects of stress and cardiovascular risk factors, and where they are otherwise vulnerable to acute cardiovascular events due to the synergistic effects of mental stress and an underlying atherothrombotic disorder. Although the exact pathway(s) underlying the interplay between depression and cardiovascular disease remains to be elucidated, the mechanisms most often implicated include hormonal variations, metabolic abnormalities, hypercoagulability, increased platelet aggregation, inflammation, and endothelial dysfunction. This article aims to review the biological and clinical links between depression and cardiovascular disease.

Cardiovascular disease - mental depression - stress - risk factor

REFERENCES

• 1 Murray CJL, Lopez AD The Global Burden of Disease. Boston, MA; Harvard University Press 1996
• 2 Kessler R C, Berglund P, Demler O National Comorbidity Survey Replication et al. The epidemiology of major depressive disorder: results from the National Comorbidity Survey Replication (NCS-R).  JAMA. 2003;  289 3095-3105
• 3 Belmaker R H, Agam G. Major depressive disorder.  N Engl J Med. 2008;  358 55-68
• 4 American Psychiatric Association .Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition, Text Revision: DSM-IV-TR. Washington, DC; American Psychiatric Publishing 2000
• 5 National Institute of Mental Health .Older adults and mental health. Bethesda, MD; US Department of Health and Human Services, National Institutes of Health, National Institute of Mental Health 2006 Available at: http://nimh.nih.gov/healthinformation/depoldermenu.cfm Accessed December 2, 2008
• 6 Ansorge M S, Hen R, Gingrich J A. Neurodevelopmental origins of depressive disorders.  Curr Opin Pharmacol. 2007;  7 8-17
• 7 Hayley S, Poulter M O, Merali Z, Anisman H. The pathogenesis of clinical depression: stressor- and cytokine-induced alterations of neuroplasticity.  Neuroscience. 2005;  135 659-678
• 8 Sowden G L, Huffman J C. The impact of mental illness on cardiac outcomes: a review for the cardiologist.  Int J Cardiol. 2009;  132 30-37
• 9 Rozanski A, Bairey C N, Krantz D S et al.. Mental stress and the induction of silent myocardial ischemia in patients with coronary artery disease.  N Engl J Med. 1988;  318 1005-1012
• 10 Whooley M A, de Jonge P, Vittinghoff E et al.. Depressive symptoms, health behaviors, and risk of cardiovascular events in patients with coronary heart disease.  JAMA. 2008;  300 2379-2388
• 11 Rosengren A, Hawken S, Ounpuu S INTERHEART investigators et al. Association of psychosocial risk factors with risk of acute myocardial infarction in 11119 cases and 13648 controls from 52 countries (the INTERHEART study): case-control study.  Lancet. 2004;  364 953-962
• 12 Anda R, Williamson D, Jones D et al.. Depressed affect, hopelessness, and the risk of ischemic heart disease in a cohort of U.S. adults.  Epidemiology. 1993;  4 285-294
• 13 Lichtman J H, Bigger Jr J T, Blumenthal J A American Heart Association Prevention Committee of the Council on Cardiovascular Nursing et al. Depression and coronary heart disease: recommendations for screening, referral, and treatment: a science advisory from the American Heart Association Prevention Committee of the Council on Cardiovascular Nursing, Council on Clinical Cardiology, Council on Epidemiology and Prevention, and Interdisciplinary Council on Quality of Care and Outcomes Research: endorsed by the American Psychiatric Association.  Circulation. 2008;  118 1768-1775
• 14 Matthews S C, Nelesen R A, Dimsdale J E. Depressive symptoms are associated with increased systemic vascular resistance to stress.  Psychosom Med. 2005;  67 509-513
• 15 Allen M T, Patterson S M. Hemoconcentration and stress: a review of physiological mechanisms and relevance for cardiovascular disease risk.  Biol Psychol. 1995;  41 1-27
• 16 Shinagawa M, Otsuka K, Murakami S et al.. Seven-day (24-h) ambulatory blood pressure monitoring, self-reported depression and quality of life scores.  Blood Press Monit. 2002;  7 69-76
• 17 Hildreth C M, Padley J R, Pilowsky P M, Goodchild A K. Impaired serotonergic regulation of heart rate may underlie reduced baroreflex sensitivity in an animal model of depression.  Am J Physiol Heart Circ Physiol. 2008;  294 H474-H480
• 18 Stein P K, Carney R M, Freedland K E et al.. Severe depression is associated with markedly reduced heart rate variability in patients with stable coronary heart disease.  J Psychosom Res. 2000;  48 493-500
• 19 Krittayaphong R, Cascio W E, Light K C et al.. Heart rate variability in patients with coronary artery disease: differences in patients with higher and lower depression scores.  Psychosom Med. 1997;  59 231-235
• 20 Bigger Jr J T, Fleiss J L, Rolnitzky L M, Steinman R C. Frequency domain measures of heart period variability to assess risk late after myocardial infarction.  J Am Coll Cardiol. 1993;  21 729-736
• 21 Sorlie P D, Garcia-Palmieri M R, Costas Jr R, Havlik R J. Hematocrit and risk of coronary heart disease: the Puerto Rico Health Program.  Am Heart J. 1981;  101 456-461
• 22 Patterson S M, Krantz D S, Gottdiener J S, Hecht G, Vargot S, Goldstein D S. Prothrombotic effects of environmental stress: changes in platelet function, hematocrit, and total plasma protein.  Psychosom Med. 1995;  57 592-599
• 23 Lowe G D. Blood rheology in arterial disease.  Clin Sci (Lond). 1986;  71 137-146
• 24 Kensey K R. The mechanistic relationships between hemorheological characteristics and cardiovascular disease.  Curr Med Res Opin. 2003;  19 587-596
• 25 Finnerty Jr F A, Buchholz J H, Guillaudeu R L. The blood volumes and plasma protein during levarterenol-induced hypertension.  J Clin Invest. 1958;  37 425-429
• 26 Cohn J N. Relationship of plasma volume changes to resistance and capacitance vessel effects of sympathomimetic amines and angiotensin in man.  Clin Sci. 1966;  30 267-278
• 27 Johanson C E, Donahue J E, Spangenberger A, Stopa E G, Duncan J A, Sharma H S. Atrial natriuretic peptide: its putative role in modulating the choroid plexus-CSF system for intracranial pressure regulation.  Acta Neurochir Suppl. 2006;  96 451-456
• 28 Arlt J, Jahn H, Kellner M, Ströhle A, Yassouridis A, Wiedemann K. Modulation of sympathetic activity by corticotropin-releasing hormone and atrial natriuretic peptide.  Neuropeptides. 2003;  37 362-368
• 29 Maack T. Role of atrial natriuretic factor in volume control.  Kidney Int. 1996;  49 1732-1737
• 30 Silver M A. The natriuretic peptide system: kidney and cardiovascular effects.  Curr Opin Nephrol Hypertens. 2006;  15 14-21
• 31 Wong M L, Dong C, Esposito K et al.. Elevated stress-hemoconcentration in major depression is normalized by antidepressant treatment: secondary analysis from a randomized, double-blind clinical trial and relevance to cardiovascular disease risk.  PLoS One. 2008;  3 e2350
• 32 Broadley A JM, Korszun A, Jones C JH, Frenneaux M P. Arterial endothelial function is impaired in treated depression.  Heart. 2002;  88 521-523
• 33 Sherwood A, Hinderliter A L, Watkins L L, Waugh R A, Blumenthal J A. Impaired endothelial function in coronary heart disease patients with depressive symptomatology.  J Am Coll Cardiol. 2005;  46 656-659
• 34 Rajagopalan S, Brook R, Rubenfire M, Pitt E, Young E, Pitt B. Abnormal brachial artery flow-mediated vasodilatation in young adults with major depression.  Am J Cardiol. 2001;  88 196-198
• 35 Rybakowski J K, Wykretowicz A, Heymann-Szlachcinska A, Wysocki H. Impairment of endothelial function in unipolar and bipolar depression.  Biol Psychiatry. 2006;  60 889-891
• 36 Broadley A J, Korszun A, Abdelaal E et al.. Metyrapone improves endothelial dysfunction in patients with treated depression.  J Am Coll Cardiol. 2006;  48 170-175
• 37 Wagner J A, Tennen H, Mansoor G A, Abbott G. History of major depressive disorder and endothelial function in postmenopausal women.  Psychosom Med. 2006;  68 80-86
• 38 Pinto V L, Brunini T M, Ferraz M R, Okinga A, Mendes-Ribeiro A C. Depression and cardiovascular disease: role of nitric oxid.  Cardiovasc Hematol Agents Med Chem. 2008;  6 142-149
• 39 Arslan A, Uzun M. Does the lower nitric oxide level cause cardiovascular changes in major depressed women?.  Eur Rev Med Pharmacol Sci. 2008;  12 309-313
• 40 Chrapko W E, Jurasz P, Radomski M W, Lara N, Archer S L, Le Mellédo J M. Decreased platelet nitric oxide synthase activity and plasma nitric oxide metabolites in major depressive disorder.  Biol Psychiatry. 2004;  56 129-134
• 41 Chrapko W, Jurasz P, Radomski M W et al.. Alteration of decreased plasma NO metabolites and platelet NO synthase activity by paroxetine in depressed patients.  Neuropsychopharmacology. 2006;  31 1286-1293
• 42 Yang E H, Lerman S, Lennon R J, Simari R D, Lerman L O, Lerman A. Relation of depression to coronary endothelial function.  Am J Cardiol. 2007;  99 1134-1136
• 43 Serebruany V L, Glassman A H, Malinin A I Sertraline AntiDepressant Heart Attack Randomized Trial Study Group et al. Platelet/endothelial biomarkers in depressed patients treated with the selective serotonin reuptake inhibitor sertraline after acute coronary events: the Sertraline AntiDepressant Heart Attack Randomized Trial (SADHART) Platelet Substudy.  Circulation. 2003;  108 939-944
• 44 Geiser F, Meier C, Wegener I et al.. Association between anxiety and factors of coagulation and fibrinolysis.  Psychother Psychosom. 2008;  77 377-383
• 45 Ogston D, McDonald G A, Fullerton H W. The influence of anxiety in tests of blood coagulability and fibrinolytic activity.  Lancet. 1962;  2 521-523
• 46 Dreyfuss F. Coagulation time of the blood, level of blood eosinophils and thrombocytes under emotional stress.  J Psychosom Res. 1956;  1 252-257
• 47 Macht D I. Influence of some drugs and of emotions on blood coagulation.  JAMA. 1952;  148 265-270
• 48 Jern C, Eriksson E, Tengborn L, Risberg B, Wadenvik H, Jern S. Changes of plasma coagulation and fibrinolysis in response to mental stress.  Thromb Haemost. 1989;  62 767-771
• 49 Davis M C. Oral contraceptive use and hemodynamic, lipid, and fibrinogen responses to smoking and stress in women.  Health Psychol. 1999;  18 122-130
• 50 Steptoe A, Kunz-Ebrecht S, Owen N et al.. Influence of socioeconomic status and job control on plasma fibrinogen responses to acute mental stress.  Psychosom Med. 2003;  65 137-144
• 51 Steptoe A, Kunz-Ebrecht S, Rumley A, Lowe G D. Prolonged elevations in haemostatic and rheological responses following psychological stress in low socioeconomic status men and women.  Thromb Haemost. 2003;  89 83-90
• 52 Palermo A, Bertalero P, Pizza N, Amelotti R, Libretti A. Decreased fibrinolytic response to adrenergic stimulation in hypertensive patients.  J Hypertens Suppl. 1989;  7 S162-S163
• 53 von Känel R, Dimsdale J E, Ziegler M G et al.. Effect of acute psychological stress on the hypercoagulable state in subjects (spousal caregivers of patients with Alzheimer's disease) with coronary or cerebrovascular disease and/or systemic hypertension.  Am J Cardiol. 2001;  87 1405-1408
• 54 von Känel R, Mills P J, Ziegler M G, Dimsdale J E. Effect of beta2-adrenergic receptor functioning and increased norepinephrine on the hypercoagulable state with mental stress.  Am Heart J. 2002;  144 68-72
• 55 Kudielka B M, Bellingrath S, von Känel R. Circulating fibrinogen but not D-dimer level is associated with vital exhaustion in school teachers.  Stress. 2008;  11 250-258
• 56 Hou S J, Yen F C, Tsai S J. Is dysfunction of the tissue plasminogen activator (tPA)-plasmin pathway a link between major depression and cardiovascular disease?.  Med Hypotheses. 2009;  72 166-168
• 57 Eskandari F, Mistry S, Martinez P E POWER (Premenopausal, Odteopenia/Osteoporosis, Women, Alendronate, Depression) Study Group et al. Younger, premenopausal women with major depressive disorder have more abdominal fat and increased serum levels of prothrombotic factors: implications for greater cardiovascular risk.  Metabolism. 2005;  54 918-924
• 58 Lahlou-Laforet K, Alhenc-Gelas M, Pornin M et al.. Relation of depressive mood to plasminogen activator inhibitor, tissue plasminogen activator, and fibrinogen levels in patients with versus without coronary heart disease.  Am J Cardiol. 2006;  97 1287-1291
• 59 Duman R S. Synaptic plasticity and mood disorders.  Mol Psychiatry. 2002;  7(Suppl 1) S29-S34
• 60 Tsai S J, Hong C J, Liou Y J, Yu Y WY, Chen T J. Plasminogen activator inhibitor-1 gene is associated with major depression and antidepressant treatment response.  Pharmacogenet Genomics. 2008;  18 869-875
• 61 Nemeroff C B, Musselman D L. Are platelets the link between depression and ischemic heart disease?.  Am Heart J. 2000;  140(4, Suppl) 57-62
• 62 Musselman D L, Tomer A, Manatunga A K et al.. Exaggerated platelet reactivity in major depression.  Am J Psychiatry. 1996;  153 1212-1217
• 63 Berk M, Kirchmann N H, Butkow N. Lithium blocks 45Ca2+ uptake into platelets in bipolar affective disorder and controls.  Clin Neuropharmacol. 1996;  19 48-51
• 64 Kroll M H, Hellums J D, McIntire L V, Schafer A I, Moake J L. Platelets and shear stress.  Blood. 1996;  88 1525-1541
• 65 Markovitz J H, Matthews K A. Platelets and coronary heart disease: potential psychophysiologic mechanisms.  Psychosom Med. 1991;  53 643-668
• 66 Laghrissi-Thode F, Wagner W R, Pollock B G, Johnson P C, Finkel M S. Elevated platelet factor 4 and beta-thromboglobulin plasma levels in depressed patients with ischemic heart disease.  Biol Psychiatry. 1997;  42 290-295
• 67 Shimbo D, Child J, Davidson K et al.. Exaggerated serotonin-mediated platelet reactivity as a possible link in depression and acute coronary syndromes.  Am J Cardiol. 2002;  89 331-333
• 68 Lett H S, Blumenthal J A, Babyak M A et al.. Depression as a risk factor for coronary artery disease: evidence, mechanisms, and treatment.  Psychosom Med. 2004;  66 305-315
• 69 Joynt K E, Whellan D J, O'Connor C M. Depression and cardiovascular disease: mechanisms of interaction.  Biol Psychiatry. 2003;  54 248-261
• 70 Akil H, Haskett R F, Young E A et al.. Multiple HPA profiles in endogenous depression: effect of age and sex on cortisol and beta-endorphin.  Biol Psychiatry. 1993;  33 73-85
• 71 Lesch K P, Laux G, Schulte H M, Pfüller H, Beckmann H. Corticotropin and cortisol response to human CRH as a probe for HPA system integrity in major depressive disorder.  Psychiatry Res. 1988;  24 25-34
• 72 Carney R M, Freedland K E, Miller G E, Jaffe A S. Depression as a risk factor for cardiac mortality and morbidity: a review of potential mechanisms.  J Psychosom Res. 2002;  53 897-902
• 73 Leonard B E. The immune system, depression and the action of antidepressants.  Prog Neuropsychopharmacol Biol Psychiatry. 2001;  25 767-780
• 74 Douglas K M, Taylor A J, O'Malley P G. Relationship between depression and C-reactive protein in a screening population.  Psychosom Med. 2004;  66 679-683
• 75 Musselman D L, Marzec U M, Manatunga A et al.. Platelet reactivity in depressed patients treated with paroxetine: preliminary findings.  Arch Gen Psychiatry. 2000;  57 875-882
• 76 Dentino A N, Pieper C F, Rao M K et al.. Association of interleukin-6 and other biologic variables with depression in older people living in the community.  J Am Geriatr Soc. 1999;  47 6-11
• 77 Maes M, Bosmans E, De Jongh R, Kenis G, Vandoolaeghe E, Neels H. Increased serum IL-6 and IL-1 receptor antagonist concentrations in major depression and treatment resistant depression.  Cytokine. 1997;  9 853-858
• 78 Gotthardt U, Schweiger U, Fahrenberg J, Lauer C J, Holsboer F, Heuser I. Cortisol, ACTH, and cardiovascular response to a cognitive challenge paradigm in aging and depression.  Am J Physiol. 1995;  268(4 Pt 2) R865-R873
• 79 Kop W J, Gottdiener J S, Tangen C M et al.. Inflammation and coagulation factors in persons >65 years of age with symptoms of depression but without evidence of myocardial ischemia.  Am J Cardiol. 2002;  89 419-424
• 80 Christensen N J. Adrenergic mechanisms in selected diseases: arterial hypertension, duodenal ulcer, primary depressive illness, malignant tumors, and ketotic hypoglycemia.  Metabolism. 1980;  29(11, Suppl 1) 1190-1197
• 81 Louis W J, Doyle A E, Anavekar S N. Plasma noradrenaline concentration and blood pressure in essential hypertension, phaeochromocytoma and depression.  Clin Sci Mol Med Suppl. 1975;  2 239s-242s
• 82 Sheline Y I, Freedland K E, Carney R M. How safe are serotonin reuptake inhibitors for depression in patients with coronary heart disease?.  Am J Med. 1997;  102 54-59
• 83 Januzzi Jr J L, Stern T A, Pasternak R C, DeSanctis R W. The influence of anxiety and depression on outcomes of patients with coronary artery disease.  Arch Intern Med. 2000;  160 1913-1921
• 84 Jiang W, Krishnan R R, O'Connor C M. Depression and heart disease: evidence of a link, and its therapeutic implications.  CNS Drugs. 2002;  16 111-127
• 85 Kubzansky L D, Kawachi I. Going to the heart of the matter: do negative emotions cause coronary heart disease?.  J Psychosom Res. 2000;  48 323-337
• 86 Rozanski A, Blumenthal J A, Kaplan J. Impact of psychological factors on the pathogenesis of cardiovascular disease and implications for therapy.  Circulation. 1999;  99 2192-2217
• 87 Rivelli S, Jiang W. Depression and ischemic heart disease: what have we learned from clinical trials?.  Curr Opin Cardiol. 2007;  22 286-291
• 88 Perlmutter J B, Frishman W H, Feinstein R E. Major depression as a risk factor for cardiovascular disease: therapeutic implications.  Heart Dis. 2000;  2 75-82
• 89 O'connor C M, Gurbel P A, Serebruany V L. Depression and ischemic heart disease.  Am Heart J. 2000;  140(4, Suppl) 63-69
• 90 Zellweger M J, Osterwalder R H, Langewitz W, Pfisterer M E. Coronary artery disease and depression.  Eur Heart J. 2004;  25 3-9
• 91 Ford D E, Mead L A, Chang P P, Cooper-Patrick L, Wang N Y, Klag M J. Depression is a risk factor for coronary artery disease in men: the precursors study.  Arch Intern Med. 1998;  158 1422-1426
• 92 Penninx B W, Beekman A T, Honig A et al.. Depression and cardiac mortality: results from a community-based longitudinal study.  Arch Gen Psychiatry. 2001;  58 221-227
• 93 Janszky I, Ahlbom A, Hallqvist J, Ahnve S. Hospitalization for depression is associated with an increased risk for myocardial infarction not explained by lifestyle, lipids, coagulation, and inflammation: the SHEEP Study.  Biol Psychiatry. 2007;  62 25-32
• 94 Ferketich A K, Schwartzbaum J A, Frid D J, Moeschberger M L. Depression as an antecedent to heart disease among women and men in the NHANES I study. National Health and Nutrition Examination Survey.  Arch Intern Med. 2000;  160 1261-1268
• 95 Rutledge T, Reis S E, Olson M B et al.. Depression symptom severity and reported treatment history in the prediction of cardiac risk in women with suspected myocardial ischemia: The NHLBI-sponsored WISE study.  Arch Gen Psychiatry. 2006;  63 874-880
• 96 Penninx B W, Guralnik J M, Mendes de Leon C F et al.. Cardiovascular events and mortality in newly and chronically depressed persons >70 years of age.  Am J Cardiol. 1998;  81 988-994
• 97 Almeida O P, Flicker L, Norman P et al.. Association of cardiovascular risk factors and disease with depression in later life.  Am J Geriatr Psychiatry. 2007;  15 506-513
• 98 Van der Kooy K, van Hout H, Marwijk H, Marten H, Stehouwer C, Beekman A. Depression and the risk for cardiovascular diseases: systematic review and meta analysis.  Int J Geriatr Psychiatry. 2007;  22 613-626
• 99 Wulsin L R, Singal B M. Do depressive symptoms increase the risk for the onset of coronary disease? A systematic quantitative review.  Psychosom Med. 2003;  65 201-210
• 100 Rutledge T, Reis V A, Linke S E, Greenberg B H, Mills P J. Depression in heart failure: a meta-analytic review of prevalence, intervention effects, and associations with clinical outcomes.  J Am Coll Cardiol. 2006;  48 1527-1537
• 101 Carney R M, Freedland K E, Sheps D S. Depression is a risk factor for mortality in coronary heart disease.  Psychosom Med. 2004;  66 799-801
• 102 Shimbo D, Davidson K W, Haas D C, Fuster V, Badimon J J. Negative impact of depression on outcomes in patients with coronary artery disease: mechanisms, treatment considerations, and future directions.  J Thromb Haemost. 2005;  3 897-908
• 103 Parissis J T, Fountoulaki K, Filippatos G, Adamopoulos S, Paraskevaidis I, Kremastinos D. Depression in coronary artery disease: novel pathophysiologic mechanisms and therapeutic implications.  Int J Cardiol. 2007;  116 153-160
• 104 Frasure-Smith N, Lespérance F, Talajic M. Depression following myocardial infarction. Impact on 6-month survival.  JAMA. 1993;  270 1819-1825
• 105 Frasure-Smith N, Lespérance F, Talajic M. Depression and 18-month prognosis after myocardial infarction.  Circulation. 1995;  91 999-1005
• 106 Horsten M, Mittleman M A, Wamala S P, Schenck-Gustafsson K, Orth-Gomér K. Depressive symptoms and lack of social integration in relation to prognosis of CHD in middle-aged women. The Stockholm Female Coronary Risk Study.  Eur Heart J. 2000;  21 1072-1080
• 107 de Jonge P, Spijkerman T A, van den Brink R H, Ormel J. Depression after myocardial infarction is a risk factor for declining health related quality of life and increased disability and cardiac complaints at 12 months.  Heart. 2006;  92 32-39
• 108 van Melle J P, de Jonge P, Spijkerman T A et al.. Prognostic association of depression following myocardial infarction with mortality and cardiovascular events: a meta-analysis.  Psychosom Med. 2004;  66 814-822
• 109 Barth J, Schumacher M, Herrmann-Lingen C. Depression as a risk factor for mortality in patients with coronary heart disease: a meta-analysis.  Psychosom Med. 2004;  66 802-813
• 110 Dokras A. Cardiovascular disease risk factors in polycystic ovary syndrome.  Semin Reprod Med. 2008;  26 39-44
• 111 Mina A, Favaloro E J, Koutts J. Hemostatic dysfunction associated with endocrine disorders as a major risk factor and cause of human morbidity and mortality: a comprehensive meta-review.  Semin Thromb Hemost. 2007;  33 798-809
• 112 Hollinrake E, Abreu A, Maifeld M, Van Voorhis B J, Dokras A. Increased risk of depressive disorders in women with polycystic ovary syndrome.  Fertil Steril. 2007;  87 1369-1376
• 113 Kerchner A, Lester W, Stuart S P, Dokras A. Risk of depression and other mental health disorders in women with polycystic ovary syndrome: a longitudinal study.  Fertil Steril. 2009;  91 207-212
• 114 Hirshkowitz M. The clinical consequences of obstructive sleep apnea and associated excessive sleepiness.  J Fam Pract. 2008;  57(8, Suppl) S9-S16
• 115 Dawson B, Taylor J, Favaloro E J. Potential benefits of improved protein intake in older people.  Nutrition Dietetics. 2008;  65 151-156
• 116 Brand-Miller J, Dickinson S, Barclay A, Allman-Farinelli M. Glycemic index, glycemic load and thrombogenesis.  Semin Thromb Hemost. 2009;  35 111-118
• 117 Singh N A, Stavrinos T M, Scarbek Y, Galambos G, Liber C, Fiatarone Singh M A. A randomized controlled trial of high versus low intensity weight training versus general practitioner care for clinical depression in older adults.  J Gerontol A Biol Sci Med Sci. 2005;  60 768-776